Cytokinetics, Incorporated (CYTK) Social Stream
CYTOKINETICS INC (CYTK) Price Targets From Analysts
Use the tables below to see what analysts covering CYTOKINETICS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-04 | 8 | $75 | $40 | $53.444 | $40.75 | 31.15% |
| 2021-12-01 | 9 | $75 | $40 | $53.5 | $40.75 | 31.29% |
| 2021-12-10 | 10 | $75 | $40 | $53.909 | $40.75 | 32.29% |
| 2021-12-21 | 10 | $75 | $40 | $54.545 | $40.75 | 33.85% |
| 2022-02-01 | 11 | $75 | $40 | $54.666 | $40.75 | 34.15% |
| 2022-02-15 | 11 | $75 | $40 | $54.5 | $40.75 | 33.74% |
| 2022-02-28 | 11 | $75 | $40 | $54.166 | $40.75 | 32.92% |
| 2022-03-02 | 11 | $75 | $40 | $53.916 | $40.75 | 32.31% |
| 2022-04-13 | 11 | $75 | $40 | $54.272 | $40.75 | 33.18% |
| 2022-04-29 | 11 | $75 | $40 | $55.181 | $40.75 | 35.41% |
| 2022-05-05 | 11 | $75 | $40 | $56.727 | $40.75 | 39.21% |
| 2022-05-16 | 11 | $80 | $40 | $59.909 | $40.75 | 47.02% |
| 2022-05-23 | 12 | $80 | $40 | $60.916 | $40.75 | 49.49% |
| 2022-05-26 | 12 | $80 | $40 | $59.5 | $40.75 | 46.01% |
| 2022-06-17 | 12 | $80 | $40 | $61.333 | $40.75 | 50.51% |
| 2022-08-05 | 10 | $80 | $54 | $64.545 | $40.75 | 58.39% |
| 2022-08-09 | 10 | $80 | $56 | $65.636 | $40.75 | 61.07% |
| 2022-08-12 | 10 | $80 | $15 | $61.545 | $40.75 | 51.03% |
| 2022-09-02 | 10 | $80 | $15 | $62.727 | $40.75 | 53.93% |
| 2022-10-03 | 11 | $82 | $15 | $64.333 | $40.75 | 57.87% |
| 2022-11-03 | 12 | $82 | $15 | $65.538 | $40.75 | 60.83% |
| 2022-11-20 | 12 | $82 | $57 | $69 | $40.75 | 69.33% |
| 2022-12-09 | 12 | $82 | $55 | $68.307 | $40.75 | 67.62% |
| 2022-12-14 | 12 | $82 | $55 | $67.923 | $40.75 | 66.68% |
| 2022-12-15 | 12 | $82 | $55 | $66.461 | $40.75 | 63.09% |
| 2022-12-20 | 14 | $82 | $55 | $65 | $40.75 | 59.51% |
| 2022-12-23 | 14 | $82 | $55 | $64.857 | $40.75 | 59.16% |
| 2023-02-14 | 14 | $80 | $47 | $62.357 | $40.75 | 53.02% |
| 2023-02-21 | 15 | $80 | $47 | $61.466 | $40.75 | 50.84% |
| 2023-03-01 | 15 | $80 | $47 | $61.4 | $40.75 | 50.67% |
| 2023-03-02 | 15 | $80 | $48 | $61.533 | $40.75 | 51% |
| 2023-03-06 | 15 | $80 | $48 | $61.933 | $40.75 | 51.98% |
| 2023-03-07 | 15 | $80 | $48 | $61.933 | $40.75 | 51.98% |
| 2023-03-20 | 15 | $80 | $48 | $61.733 | $40.75 | 51.49% |
| 2023-03-31 | 15 | $80 | $42 | $61.2 | $40.75 | 50.18% |
| 2023-04-03 | 15 | $80 | $42 | $60.533 | $40.75 | 48.55% |
| 2023-04-18 | 15 | $80 | $42 | $60.2 | $40.75 | 47.73% |
| 2023-05-05 | 15 | $80 | $41 | $60.466 | $40.75 | 48.38% |
| 2023-05-16 | 15 | $80 | $41 | $60.533 | $40.75 | 48.55% |
The Trend in the Analyst Price Target
Over the past 25 months, CYTK's average price target has gone up $29.17.
CYTK reports an average of 51.97% for its upside potential over the past 51 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-06-17 | 12 | 80 | 40 | 61.333 | 40.58 | 51.14% |
| 2022-09-02 | 10 | 80 | 15 | 62.727 | 54.06 | 16.03% |
| 2022-11-03 | 12 | 82 | 15 | 65.538 | 39.75 | 64.88% |
| 2022-11-08 | 12 | 82 | 57 | 69.000 | 38.25 | 80.39% |
| 2023-02-14 | 14 | 80 | 47 | 62.357 | 43.35 | 43.85% |
CYTK Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.27 | 12 | 2 | 1 | 0 | 0 | 15 |
The Trend in the Broker Recommendations
CYTK's average broker recommendation rating worsened by 0.1 over the prior 26 weeks.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for CYTK as an investment opportunity.
- In terms of how CYTOKINETICS INC fares relative to stocks in the mid market cap category, note that its number of analysts covering the stock is higher than 4050.86% of that group.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, CYTOKINETICS INC's average analyst price target is greater than 3536.58% of them.
- In terms of how CYTOKINETICS INC fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is higher than 1394.77% of that group.
- In terms of how CYTOKINETICS INC fares relative to stocks in the mid market cap category, note that its variance in analysts' estimates is lower than -3016.7% of that group.
Stocks similar to CYTOKINETICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are DVAX, TGTX, and OPK.
View All Top Stocks by Price Target
What is the outlook for CYTK? Use POWR Ratings for clearer insight into price direction.